Surgical margin status at prostatectomy is an important predictor of biochemical recurrence (BCR). The current convention is to categorize a margin as negative if tumor cells are not at the inked margin, even if they are within a few cells of the margin. We hypothesized that cancer within 0.
P ositive surgical margins at the time of radical prostatectomy (RP) are an independent predictor of biochemical recurrence (BCR), local recurrence, distant metastasis, and, in some series, prostate cancer (PCa)-specific mortality. [1] [2] [3] [4] [5] [6] A positive surgical margin may also be the strongest predictor of the utility of adjuvant radiotherapy (XRT) after RP. 7 However, some men with clinically localized disease do experience BCR and progression even in the absence of a positive surgical margin. 1, 6, 8, 9 If positive surgical margins impact recurrence rates by leaving cancer tissue in the body, it is conceivable that close but negative surgical margins may have an impact on outcomes. Very small tumor-to-margin distances may represent occult positive surgical margins that are simply not sampled in the standard sections of a totally embedded RP. Small tumor-to-margin distances correlate with increased recurrence rates of other cancers. Margin distances of <2 mm correlate with increased rates of breast cancer recurrence. 10, 11 Likewise, circumferential resection margins of rectal carcinomas that are <2 mm correlate with increased rates of local and distant recurrences and decreased overall survival. 12, 13 Most studies of PCa have not found an association between margin distance and recurrence rates. [14] [15] [16] However, these studies were limited by a small sample size. One recent study reported that margin distances of <0.1 mm are associated with increased recurrence rates. 17 At our institution, we have categorized the margin status of RP performed for PCa on the basis of threshold values of tumor-to-margin distances. We hypothesized that a small tumor-to-margin distance in margin-negative RP specimens correlates highly with occult margin positivity and predicts for increased recurrence rates.
MATERIALS AND METHODS

Study Population
We queried a prospectively maintained database at our institution for all RP specimens since 1998. Beginning that year, the margin status of the specimens was classified as positive (ink touching tumor cells), close (tumor cells within 0.1 mm of the inked margin), or negative ( Fig. 1) . The large majority of specimens were reviewed and reported by one genitourinary pathologist (L.D.T.) before 2005. From 2005 to the present, multiple pathologists reported RP specimens using a standard prostatectomy template. All RP specimens were handled on the basis of a standard protocol. In brief, the surface of the specimens was inked using 4 colors and fixed overnight in phosphatebuffered formalin. Serial transverse sections were then made from the apex to the base. These were submitted for processing and embedding in paraffin as approximately 3-mm-thick blocks, from which single 4-mm-thick sections were taken. Cancers from 1998 to 2005 were graded according to criteria conventional at the time. 18 Cancers after 2005 were graded using the 2005 ISUP Modified Gleason grading system. 19 Tumor volume was determined morphometrically. The regions of cancer on the slides from each case were circumscribed by ink. The area of each cancer region was determined by superimposing a template over the slides. The volume of cancer in each case was the multiplicand of the summed areas of cancer and average block thickness, which is 0.3 cm.
Patients were excluded from this analysis if they had received neoadjuvant therapy, had node-positive disease, or if their postoperative prostate-specific antigen (PSA) did not reach an undetectable level. Patients missing stage, cancer grade, or follow-up data were also excluded, as were patients who underwent salvage RP. Follow-up schedules were individualized on the basis of surgeon preference and patient disease characteristics.
Data Collection and Coding
Data collection was performed after approval from the Institutional Review Board. Information regarding age, race, preoperative PSA, pathologic T stage, Gleason score, surgical approach, use of adjuvant XRT, total prostate volume, and PCa tumor volume was collected. Preoperative PSA was divided into categorizes of <4, 4 to 10, and Z10 ng/mL. Age was analyzed as the categorical variables <50, 50 to 59, 60 to 69, and Z70. PCa tumor volume was categorized into 1.0 cm 3 increments (0 to 0.9, 1.0 to 1.9, 2.0 to 2.9, 3.0 to 3.9, Z4.0), and prostate volume was categorized into quartiles.
Disease progression was defined as a PSAZ0.2 ng/mL, treatment with salvage XRT, or initiation of androgen deprivation therapy. Time to disease progression was determined from the date of RP.
Statistical Analysis
Differences in patient demographic and pathologic variables by margin status were compared by w 2 tests. Univariate and multivariate Cox proportional hazards regression analyses were used to determine the hazard ratios (HRs) and 95% confidence intervals (CIs) for risk for recurrence. All of the above covariates were included in the multivariate model. The proportional hazards assumption for the Cox model was evaluated with 
RESULTS
Data from 1588 patients were available for analysis. Patient characteristics are reported in Table 1 . The overall positive surgical margin rate was 18.8%. Margins that were close represented 15% of pathology specimens. Table 2 shows the distribution of pathologic factors by margin status. Significant differences in margin status were observed within pathologic T stage and Gleason score (both P < 0.001). Margins that were close and positive were more frequent in patients with pT3 tumors compared with those with pT2 tumors. The proportion of cases with margins close and positive increased with higher Gleason grades. Higher preoperative PSA values were associated with higher rates of positive surgical margins (P < 0.01).
Overall, 193 of 1588 patients (12.5%) experienced disease recurrence with a median follow-up of 25 months (range, 0.26 to 149 mo). Adjuvant XRT was infrequently used (1.3% of the total cohort), most commonly (8%) for those patients with pT3 tumors and/or positive surgical margins.
The overall recurrence rates, stratified by margin status and unadjusted risk for recurrence by clinical and pathologic factors, are reported in Tables 3 and 4 , respectively. Compared with patients with a negative surgical margin, close margins predicted higher risk for recurrence (HR 1.72; 95% CI, 1.15-2.57). Figure 2 shows Kaplan-Meier recurrence-free survival curves for patients stratified by margin status. Other univariate predictors of recurrence were pathologic T stage, larger tumor volumes, higher Gleason score, the use of adjuvant XRT, and higher preoperative serum PSA levels. In the multivariate model, positive surgical margins and close surgical margins remained independent predictors of recurrence. Compared with those with a negative surgical margin, a close margin was associated with a >50% increased risk for recurrence (HR 1.53; 95% CI, 1.00-2.32). There was no significant difference in recurrence between close and positive surgical margins (P = 0.15). Subgroup analysis for those patients with >2 years of follow-up revealed an even higher risk for recurrence in our multivariate model for those with close margins compared with those with negative margins (HR 1.71; 95% CI, 0.93-3.13, P = 0.08). Excluding those who received adjuvant XRT also did not significantly change the risk estimates (data not shown).
DISCUSSION
In this study, we found that patients whose tumors are within 0.1 mm of the surgical margin have significantly higher rates of recurrence than those patients whose prostatectomy specimens have negative surgical margins. Furthermore, the recurrence rates of tumors with close margins were similar to those with positive surgical margins. Our data support the hypothesis that tumors that are within 0.1 mm of the surgical margin may represent occult positive margins. 20 Two studies, using an ocular micrometer to measure tumor-to-margin distances in RP specimens, looked at the risk for BCR of cancer in node-negative cases. In a casecontrol study of 101 men, of whom 52 experienced biochemical progression, there was no difference in disease recurrence on the basis of mean tumor-to-margin distances. Furthermore, the tumor-to-margin distance was not associated with BCR in their multivariate model. 15 However, progression after RP is not solely determined by margin status as there are multiple risk factors reported for progression. [21] [22] [23] [24] [25] Therefore, a retrospective sampling of 52 patients who experienced tumor progression may not accurately reflect the prognostic value of the tumor-to-margin distance. Further, that study was of men treated from 1982 to 1988, which may not be representative of a contemporary, PSA-screened population. A second study of 278 consecutive patients with marginnegative PCa found that patients who experienced BCR had closer median tumor-to-margin distances (0.4 mm; range, 0.0 to 1.8) than those without BCR (0.5 mm; range, 0.0 to 5.0). However, this finding was not statistically significant (P = 0.06). As only 23 patients experienced BCR, multivariate analysis was not performed. Our analysis of a much larger population (n = 1588) has greater power to detect a significant difference. Rather than measuring an absolute tumor-to-margin distance, we prospectively categorized our cases by margin status: positive, within 0.1 mm of the margin, and negative. This approach helps to minimize the effect of outliers that may skew data distribution. In the first case-control study described above, the median tumor-to-margin distance was 0.3 mm in the controls and 0.275 mm in the cases. 15 In the second study, the median distance was 0.5 mm. 14 Potentially, the previous studies of tumor-to-margin distance may have failed to find a significant difference because too large a distance was analyzed. By categorizing patients on the basis of a shorter tumor-to-margin dis-tance of 0.1 mm, we were more likely to find a true difference.
In a recently published study, Lu et al 17 examined the prognostic importance of tumor-to-margin distances of <0.1 mm. Of 894 patients with a median follow-up of 9.9 years, 277 experienced BCR. The multivariate analysis found that close margins were significantly associated with BCR, characterized by an HR of 2.1 (95% CI, 1.04-4.33). These results are similar to ours, wherein we also found a statistically significant recurrence rate that was 1.53 times higher in those with close margins than those with negative surgical margins. It is likely that there is a continuum of strength of correlation between recurrence rate and tumor-to-margin distance. This explanation is biologically plausible if we assume that the majority of patients with increased recurrence rates result from occult positive margins. The closer the surgical margin, the more likely it is that cancer cells are actually at the surgical margin deeper in a paraffin block. Humphrey 26 showed that increasing the number of sections of the margins of an RP specimen increases the extent of margin positivity. That finding is not surprising as we do not routinely sample for margin-positive events to a degree that will identify all such events. Conventional practice is to obtain 4-or 5-mm-thick sections of 2-to 3-mm-thick blocks of tissue. This represents a sampling frequency of 1 in 400 to 1 in 750. There are some limitations to our study. First, pathologists may vary in their visual estimates of a 0.1 mm tumor-to-margin distance. As previously reported, genitourinary pathologists vary in their assessments of surgical margin status. 27 However, our finding may be more realistic and generalized, as several pathologists were involved with the pathologic interpretations. This staffing characterizes most practices. Second, the median follow-up of our patient cohort was only 25 months (range, 0.26 to 149 mo). Despite this short follow-up, we had enough events (n = 193) to find a difference in recurrence rates categorized by margin distance. We would expect that further follow-up will strengthen the association between tumor-to-margin distance and recurrence rates as was shown in our subgroup analysis of those patients with at least 2 years of follow-up.
The use of BCR as an endpoint may be seen as a limitation, as not all of those who suffer a recurrence will progress to death. [28] [29] [30] However, using cancer-specific survival as the primary endpoint ignores the patient distress and morbidity resulting from both disease progression and the side effects associated with treatment. In addition, showing a difference in cancer-specific survival by margin status would require patient numbers well beyond the scope of this study.
Finally, we did not use an ocular micrometer to measure tumor-to-margin distance. Instead we used a simpler approach of stratifying distances on the basis of visually estimating whether the tumor was within 0.1 mm of the margin. A readily available measurement tool is the microscope. In one widely used microscope, one fifth of the visual field diameter viewed through a Â 40 objective and Â 10 ocular is 0.1 mm.
Despite these limitations, we have shown in a large cohort of PCa patients treated with RP that men with a close surgical margin, defined as a tumor-to-surgical margin distance of <0.1 mm, have an increased risk for recurrence compared with those with negative margins. The risk for recurrence in this group is not statistically 
